An Italian Experience on Grade 3b Follicular Lymphoma (FL3b-Oss-2015)

Azienda Ospedaliera Città della Salute e della Scienza di Torino

Status: Unknown

Conditions: Grade 3b Follicular Lymphoma

Study type: Observational

Funder types: Other

Identifiers

NCT02927717

FL3b-Oss-2015

Details and patient eligibility

About

Study purpose is to evaluate baseline clinical data, outcome after front-line Rituximab containing chemotherapy and survival in patients with grade 3b Follicular Lymphoma.

Also an histological central review is planned in order to re-assess baseline diagnosis according to new 2016 World Health Organization (WHO) criteria.

Enrollment: 60 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of grade 3b Follicular Lymphoma
• Age > 18 years
• Front-line treatment with Rituximab containing chemotherapy
• Availability of histological sample for central review

Exclusion criteria

• Other lymphoma diagnosis